iglarlixi
Showing 1 - 5 of 5
Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Glucose, High Blood
- IGlarLixi
- Dulaglutide
-
Cheonju, Chungcheongbuk-do, Korea, Republic ofChungbuk National University Hospital
Jul 19, 2022
Type 2 Diabetes Treated With Insulin Trial in Prague (IGlarLixi, MDI - Multiple dose insulin injection)
Recruiting
- Type 2 Diabetes Treated With Insulin
- IGlarLixi
- MDI - Multiple dose insulin injection
-
Prague, CzechiaInstitute for Clinical and Experimental Medicine
Jul 16, 2021
Type 2 Diabetes Trial in Canada (iGlarLixi, Insulin Glargine, Metformin)
Completed
- Type 2 Diabetes Mellitus
- iGlarLixi
- +3 more
-
Calgary, Alberta, Canada
- +7 more
Nov 10, 2020
Diabetes, Type 2 Trial in Tübingen (IGlarLixi, Insulin Glargine 100 UNT/ML)
Terminated
- Diabetes Mellitus, Type 2
- IGlarLixi
- Insulin Glargine 100 UNT/ML
-
Tübingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Jul 8, 2020
Type 2 Diabetes Trial in Naples (IDegLira, IGlarLixi, Insulin/Canaglifozin)
Completed
- Type 2 Diabetes
- IDegLira
- +5 more
-
Naples, ItalyUnit of Endocrinology and Metabolic Diseases
Oct 20, 2020